Lv1
59 积分 2021-12-15 加入
A retrospective observational study of oral ivarmacitinib and narrow-band ultraviolet-B in refractory progressive vitiligo
1天前
已关闭
Definition of Severity and Relapse for Vitiligo
10天前
已完结
Oral and Topical Janus Kinase Inhibitors in Patients With Cutaneous T‐Cell Lymphoma: A Real‐World Single‐Center Experience
1个月前
已完结
Mycosis fungoides/Sézary syndrome and systemic Janus kinase inhibitors: a real-world retrospective study on behalf of the EORTC CLTG
1个月前
已完结
Severely pruritic mycosis fungoides successfully treated with upadacitinib
1个月前
已完结
The role of upadacitinib in refractory dermatomyositis: A systematic review
1个月前
已完结
Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib in patients with extensive vitiligo in a phase 2, randomized, double-blinded, dose-ranging, placebo-controlled study
1个月前
已完结
Clinical characteristics, subtype classification, and prognostic factors of ophiasis: A retrospective study of 150 patients with therapeutic implications
2个月前
已关闭
Effectiveness and safety of secukinumab in Chinese patients with moderate to severe plaque psoriasis in real‐world practice
2个月前
已完结
皖公网安备34019202002308
